{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:17:34Z","timestamp":1768353454723,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11914-009-0009-0","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T10:59:35Z","timestamp":1248087575000},"page":"47-52","source":"Crossref","is-referenced-by-count":40,"title":["Thyroid-stimulating hormone, thyroid hormones, and bone loss"],"prefix":"10.1007","volume":"7","author":[{"given":"Mone","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry F.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberta","family":"Zallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry C.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jameel","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surinder S.","family":"Moonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Mechanick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,21]]},"reference":[{"key":"9_CR1","first-page":"68","volume-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","author":"L.S. Stepnick","year":"2004","unstructured":"Stepnick LS: The frequency of bone disease. In Bone Health and Osteoporosis: A Report of the Surgeon General. Edited by McGowan JA, Raisz LG, Noonan AS, Elderkin AL. Washington, DC: Office of the US Surgeon General; 2004:68\u201387."},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","volume":"130","author":"S.L. Greenspan","year":"1999","unstructured":"Greenspan SL, Greenspan FS: The effect of thyroid hormone on skeletal integrity. Ann Intern Med 1999, 130:750\u2013758.","journal-title":"Ann Intern Med"},{"key":"9_CR3","volume-title":"Die Fibrose Oder Deformierende Ostitis, die Osteomalazie und die Osteoplastische Carzinose in Ihren Gegenseitigen Beziehungen","author":"F. Recklinghausen Von","year":"1891","unstructured":"Von Recklinghausen F: Die Fibrose Oder Deformierende Ostitis, die Osteomalazie und die Osteoplastische Carzinose in Ihren Gegenseitigen Beziehungen. Berlin: George Reimer; 1891."},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/thy.1994.4.319","volume":"4","author":"D.S. Ross","year":"1994","unstructured":"Ross DS: Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 1994, 4:319\u2013326.","journal-title":"Thyroid"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/thy.1994.4.143","volume":"4","author":"D.T. Baran","year":"1994","unstructured":"Baran DT: Thyroid hormone and bone mass: the clinician\u2019s dilemma. Thyroid 1994, 4:143\u2013144.","journal-title":"Thyroid"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2265.2004.02053.x","volume":"61","author":"E. Murphy","year":"2004","unstructured":"Murphy E, Williams GR: The thyroid and the skeleton. Clin Endocr 2004, 61:285\u2013298.","journal-title":"Clin Endocr"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1089\/thy.1994.4.508","volume":"4","author":"K.W. Wenzel","year":"1994","unstructured":"Wenzel KW: Thyroid hormone and bone. Thyroid 1994, 4:508\u2013509.","journal-title":"Thyroid"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/joe.0.1330327","volume":"133","author":"T.J. Allain","year":"1992","unstructured":"Allain TJ, Chambers TJ, Flanagan AM, McGregor AM: Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. J Endocrinol 1992, 133:327\u2013331.","journal-title":"J Endocrinol"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/endo.134.1.8275930","volume":"134","author":"J.M. Britto","year":"1994","unstructured":"Britto JM, Fenton AJ, Holloway WR, Nicholson GC: Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994, 134:169\u2013176.","journal-title":"Endocrinology"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/joe.0.1600097","volume":"160","author":"C.H. Kim","year":"1999","unstructured":"Kim CH, Kim HK, Shong YK, et al.: Thyroid hormone stimulates basal and interleukin (IL)-1-induced IL-6 production in human bone marrow stromal cells: a possible mediator of thyroid hormone-induced bone loss. J Endocrinol 1999, 160:97\u2013102.","journal-title":"J Endocrinol"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1359\/jbmr.1998.13.9.1398","volume":"13","author":"Y. Ishikawa","year":"1998","unstructured":"Ishikawa Y, Genge BR, Wuthier RE, Wu LN.: Thyroid hormone inhibits growth and stimulates terminal differentiation of epiphyseal growth plate chondrocytes. J Bone Miner Res 1998, 13:1398\u20131411.","journal-title":"J Bone Miner Res"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1210\/me.2007-0157","volume":"21","author":"J.H. Bassett","year":"2007","unstructured":"Bassett JH, Nordstr\u00f6m K, Boyde A, et al.: Thyroid status during skeletal development determines adult bone structure and mineralization. Mol Endocrinol 2007, 21:1893\u20131904.","journal-title":"Mol Endocrinol"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000182315","volume":"37","author":"E. Menis De","year":"1992","unstructured":"De Menis E, Da Rin G, Roiter I, et al.: Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma. Horm Res 1992, 37:217\u2013220.","journal-title":"Horm Res"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1507\/endocrj.50.657","volume":"50","author":"G. Kisakol","year":"2003","unstructured":"Kisakol G, Kaya A, Gonen S, Tunc R: Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism. Endocr J 2003, 50:657\u2013661.","journal-title":"Endocr J"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.1993.tb02403.x","volume":"39","author":"J. F\u00f6ldes","year":"1993","unstructured":"F\u00f6ldes J, Tarj\u00e1n G, Szathmari M, et al.: Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocr 1993, 39:521\u2013527.","journal-title":"Clin Endocr"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/thy.1999.9.539","volume":"9","author":"A. Gurlek","year":"1999","unstructured":"Gurlek A, Gedik O: Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid 1999, 9:539\u2013543.","journal-title":"Thyroid"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bone.2005.01.017","volume":"36","author":"J.M. Kindblom","year":"2005","unstructured":"Kindblom JM, Gevers EF, Skrtic SM, et al.: Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors. Bone 2005, 36:607\u2013616.","journal-title":"Bone"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1101\/gad.13.10.1329","volume":"13","author":"S. G\u00f6the","year":"1999","unstructured":"G\u00f6the S, Wang Z, Ng L, et al.: Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 1999, 13:1329\u20131341.","journal-title":"Genes Dev"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-134-7-200104030-00009","volume":"134","author":"D.C. Bauer","year":"2001","unstructured":"Bauer DC, Ettinger B, Nevitt MC, et al.: Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001, 134:561\u2013568.","journal-title":"Ann Intern Med"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bone.2006.12.001","volume":"40","author":"M.S. Morris","year":"2007","unstructured":"Morris MS: The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women. Bone 2007, 40:1128\u20131134.","journal-title":"Bone"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/me.2007-0033","volume":"21","author":"J.H. Bassett","year":"2007","unstructured":"Bassett JH, O\u2019shea PJ, Sriskantharajah S, et al.: Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol 2007, 21:1095\u20131107.","journal-title":"Mol Endocrinol"},{"key":"9_CR22","doi-asserted-by":"crossref","unstructured":"Bassett D, Williams G: The skeletal phenotypes of TRalpha and TRbeta mutant mice. J Mol Endocrinol 2008 Dec 29 (Epub ahead of print).","DOI":"10.1677\/JME-08-0142"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","volume":"115","author":"E. Abe","year":"2003","unstructured":"Abe E, Marians RC, Yu W, et al.: TSH is a negative regulator of skeletal remodeling. Cell 2003, 115:151\u2013162.","journal-title":"Cell"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0092-8674(03)00812-2","volume":"115","author":"D. Novack","year":"2003","unstructured":"Novack D: TSH, the bone suppressing hormone. Cell 2003, 115:129\u2013130.","journal-title":"Cell"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1089\/thy.2006.16.1075","volume":"16","author":"M. Zaidi","year":"2006","unstructured":"Zaidi M, Sun L, Davies TF, Abe E: Low TSH triggers bone loss: fact or fiction? Thyroid 2006, 16:1075\u20131076.","journal-title":"Thyroid"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1073\/pnas.0600427103","volume":"103","author":"H. Hase","year":"2006","unstructured":"Hase H, Ando T, Eldeiry L, et al.: TNFalpha mediates the skeletal effects of thyroid-stimulating hormone. Proc Natl Acad Sci U S A 2006, 103:12849\u201312854.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1073\/pnas.0712395105","volume":"105","author":"L. Sun","year":"2008","unstructured":"Sun L, Vukicevic S, Baliram R, et al.: Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci U S A 2008, 105:4289\u20134294.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1210\/me.2007-0460","volume":"22","author":"K. Yamoah","year":"2008","unstructured":"Yamoah K, Brebene A, Baliram R, et al.: High-mobility group box proteins modulate tumor necrosis factor-alpha expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence. Mol Endocrinol 2008, 22:1141\u20131153.","journal-title":"Mol Endocrinol"},{"key":"9_CR29","unstructured":"Ma R, Latif R, Zaidi M, Davies T: Thyroid and bone: TSH inhibits osteoclastogenesis from embryonic stem cells. Presented at the 91st Annual Meeting of the Endocrine Society. Washington DC; June 10\u201313, 2009."},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/me.2007-0221","volume":"22","author":"J.H. Bassett","year":"2008","unstructured":"Bassett JH, Williams AJ, Murphy E, et al.: A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol 2008, 22:501\u2013512.","journal-title":"Mol Endocrinol"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1359\/JBMR.041126","volume":"20","author":"G. Mazziotti","year":"2005","unstructured":"Mazziotti G, Sorvillo F, Piscopo M, et al.: Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma J Bone Miner Res 2005, 20:480\u2013486.","journal-title":"J Bone Miner Res"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.070302","volume":"22","author":"T.K. Sampath","year":"2007","unstructured":"Sampath TK, Simic P, Sendak R, et al.: Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. J Bone Miner Res 2007, 22:849\u2013859.","journal-title":"J Bone Miner Res"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.14310\/horm.2002.1111026","volume":"6","author":"M. Giusti","year":"2007","unstructured":"Giusti M, Cecoli F, Ghiara C, et al.: Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma. Hormones (Athens) 2007, 6:304\u2013313.","journal-title":"Hormones (Athens)"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/thy.2007.0166","volume":"18","author":"G. Martini","year":"2008","unstructured":"Martini G, Gennari L, De Paola V, et al.: The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. Thyroid 2008, 18:455\u2013460.","journal-title":"Thyroid"},{"key":"9_CR35","first-page":"121","volume":"42","author":"I. Zofkova","year":"2008","unstructured":"Zofkova I, Hill M: Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women. Endocr Regul 2008, 42:121\u2013127.","journal-title":"Endocr Regul"},{"key":"9_CR36","first-page":"475","volume":"60","author":"S. Vignera La","year":"2008","unstructured":"La Vignera S, Vicari E, Tumino S, et al.: L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history. Minerva Ginecol 2008, 60:475\u2013484.","journal-title":"Minerva Ginecol"},{"key":"9_CR37","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/thy.2008.0158","volume":"18","author":"G. Grimnes","year":"2008","unstructured":"Grimnes G, Emaus N, Joakimsen RM, et al.: The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Troms. Thyroid 2008, 18:1147\u20131155.","journal-title":"Thyroid"},{"key":"9_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2007.0186","volume":"18","author":"P. Mikosch","year":"2008","unstructured":"Mikosch P, Kerschan-Schindl K, Woloszczuk W, et al.: High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy. Thyroid 2008, 18:27\u201333.","journal-title":"Thyroid"},{"key":"9_CR39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-08-0038","volume":"159","author":"K.A. Heemstra","year":"2008","unstructured":"Heemstra KA, van der Deure WM, Peeters RP, et al.: Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. Eur J Endocrinol 2008, 159:69\u201376.","journal-title":"Eur J Endocrinol"},{"key":"9_CR40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1507\/endocrj.K06-201","volume":"54","author":"M. Nagata","year":"2007","unstructured":"Nagata M, Suzuki A, Sekiguchi S, et al.: Subclinical hypothyroidism is related to lower heel QUS in postmenopausal women. Endocr J 2007, 54:625\u2013630.","journal-title":"Endocr J"},{"key":"9_CR41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2265.2007.03016.x","volume":"68","author":"W.M. Deure van der","year":"2008","unstructured":"van der Deure WM, Uitterlinden AG, Hofman A, et al.: Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol (Oxf) 2008, 68:175\u2013181.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl1","key":"9_CR42","first-page":"S341","volume":"20","author":"O.M.E. Albagha","year":"2005","unstructured":"Albagha OME, Natarajan R, Reid DM, et al.: The D272E polymorphism of the human thyroid stimulating hormone receptor is associated with bone mineral density and bone loss in women from the UK [abstract M115]. J Bone Miner Res 2005, 20(Suppl 1):S341.","journal-title":"J Bone Miner Res"},{"key":"9_CR43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L. Sun","year":"2006","unstructured":"Sun L, Peng Y, Sharrow AC, et al.: FSH directly regulates bone mass. Cell 2006, 125:247\u2013260.","journal-title":"Cell"},{"key":"9_CR44","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1073\/pnas.0606805103","volume":"103","author":"J. Iqbal","year":"2006","unstructured":"Iqbal J, Sun L, Kumar TR, et al.: Follicle stimulating hormone stimulates TNF production from immune cells to trigger osteoclast and osteoblast formation. Proc Natl Acad Sci U S A 2006, 103:14925\u201314930.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00198-002-1307-x","volume":"14","author":"M.R. Sowers","year":"2003","unstructured":"Sowers MR, Greendale GA, Bondarenko I, et al.: Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int 2003, 14:191\u2013197.","journal-title":"Osteoporos Int"},{"key":"9_CR46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00774-004-0495-1","volume":"22","author":"B. Devleta","year":"2004","unstructured":"Devleta B, Adem B, Senada SJ: Hypergonadotropic amenorrhea and bone density: new approach to an old problem. Bone Miner Metab 2004, 22:360\u2013364.","journal-title":"Bone Miner Metab"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-009-0009-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0009-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:46:39Z","timestamp":1710495999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-009-0009-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s11914-009-0009-0","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}